Current trends and characteristics of hepatocellular carcinoma in patients with autoimmune liver diseases
EI Rigopoulou, GN Dalekos - Cancers, 2021 - mdpi.com
Simple Summary While hepatocellular carcinoma (HCC) is inextricably linked to underlying
cirrhosis due to chronic viral hepatitis, alcohol consumption, and non-alcoholic fatty liver …
cirrhosis due to chronic viral hepatitis, alcohol consumption, and non-alcoholic fatty liver …
NAFLD and autoimmune hepatitis: do not judge a book by its cover
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease (almost
25% of the general population). Autoimmune hepatitis (AIH) is a relatively rare liver disease …
25% of the general population). Autoimmune hepatitis (AIH) is a relatively rare liver disease …
[HTML][HTML] KASL clinical practice guidelines for management of autoimmune hepatitis 2022
Korean Association for the Study of the … - Clinical and …, 2023 - ncbi.nlm.nih.gov
Autoimmune hepatitis (AIH) is an inflammatory liver disease of unknown etiology caused by
an autoimmune mechanism. It can occur in all age groups and manifest as almost every type …
an autoimmune mechanism. It can occur in all age groups and manifest as almost every type …
Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction
Y Gaber, M AbdAllah, A Salama, M Sayed… - Expert Review of …, 2021 - Taylor & Francis
Introduction Metabolic-associated fatty liver disease (MAFLD) is the most common liver
disease globally, and affects about a quarter of the general population. Autoimmune …
disease globally, and affects about a quarter of the general population. Autoimmune …
[HTML][HTML] Treatment of autoimmune hepatitis
자경김 - The Korean Journal of Gastroenterology, 2023 - synapse.koreamed.org
Autoimmune hepatitis (AIH) is a chronic liver disease, characterized by elevated levels of
transaminases, immunoglobulin G, and positive autoantibodies. The disease course is …
transaminases, immunoglobulin G, and positive autoantibodies. The disease course is …
Impact of hepatic steatosis on treatment response of autoimmune hepatitis: A retrospective multicentre analysis
P Liu, M Li, L Zhao, H Yu, C Zhao, J Chen… - Frontiers in …, 2022 - frontiersin.org
Background There is a paucity of data on whether steatosis impacts autoimmune hepatitis
(AIH) treatment response. We aimed to evaluate the influence of baseline steatosis on the …
(AIH) treatment response. We aimed to evaluate the influence of baseline steatosis on the …
Non-alcoholic steatohepatitis or autoimmune hepatitis? Sometimes a closer look under the surface is needed
GN Dalekos, NK Gatselis… - BMJ Case Reports …, 2020 - casereports.bmj.com
Non-alcoholic fatty liver disease (NAFLD) is nowadays the most common liver disease
worldwide. Autoimmune hepatitis (AIH) is a relatively rare disease of the liver characterised …
worldwide. Autoimmune hepatitis (AIH) is a relatively rare disease of the liver characterised …
Patients With Autoimmune Hepatitis and Nonalcoholic Fatty Liver Disease: Characteristics, Treatment, and Outcomes
J Strzepka, BA Schwartz, EM Ritz… - Journal of Clinical …, 2024 - journals.lww.com
Background: AIH is a relatively rare and heterogeneously presenting liver disease of
unknown etiology. NAFLD is a leading cause of liver disease worldwide. AIH treatment …
unknown etiology. NAFLD is a leading cause of liver disease worldwide. AIH treatment …
Current paradigm and treatment options for autoimmune hepatitis
LS Kornerup, L Grønbæk, MB Kjær… - Comprehensive Guide to …, 2023 - Elsevier
Autoimmune hepatitis (AIH) is a chronic autoimmune inflammatory liver disease with a
sinister prognosis if untreated. Still, in patients on immunosuppressive treatment, there is …
sinister prognosis if untreated. Still, in patients on immunosuppressive treatment, there is …